Cinacalcet in Patients with Chronic Kidney Disease: A Cumulative Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Calcimimetic agents lower serum parathyroid hormone levels in people with chronic kidney disease (CKD), but treatment effects on patient-relevant outcomes are uncertain. We conducted a systematic review and meta-analysis to summarize the benefits and harms of calcimimetic therapy in adul...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmer, Suetonia C., Nistor, Ionut, Craig, Jonathan C., Pellegrini, Fabio, Messa, Piergiorgio, Tonelli, Marcello, Covic, Adrian, Strippoli, Giovanni F. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640084/
https://www.ncbi.nlm.nih.gov/pubmed/23637579
http://dx.doi.org/10.1371/journal.pmed.1001436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640084/
https://www.ncbi.nlm.nih.gov/pubmed/23637579
http://dx.doi.org/10.1371/journal.pmed.1001436

Ejemplares similares